LISATA THERAPEUTICS, INC. Increase (Decrease) in Interest Payable, Net
LISATA THERAPEUTICS, INC. (LSTA) reported Increase (Decrease) in Interest Payable, Net of $36.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2014-03-13
- LISATA THERAPEUTICS, INC. increase (decrease) in interest payable, net for fiscal 2013 was $36.00K.
| Period end | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|
| 2013-12-31 | $36.00K 10-K · filed 2014-03-13 |
| 2012-12-31 | $36.00K 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |